Biochemical markers as predictors of bone remodelling in dental disorders: A narrative description of literature

Clinical Cases in Mineral and Bone Metabolism

Volumn 9, Issue 2, 2012, Pages 100-106

  Duvina, Marco ^a   Barbato, Luigi ^a   Brancato, Leila ^a   Delle Rose, Giovanna ^a   Amunni, Franco ^a   Tonelli, Paolo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Odontogenic cyst; Osteoporosis; Periodontitis; Rankl; Serum marker

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR;

ALVEOLAR BONE LOSS; BIOCHEMISTRY; BONE REMODELING; BONE RESECTION; CYST; DISEASE COURSE; HUMAN; INFLAMMATORY CYST; JAW OSTEONECROSIS; NONHUMAN; ODONTOGENIC CYST; ODONTOGENIC KERATOCYST; PERIODONTITIS; PROTEIN BLOOD LEVEL; REVIEW; TERATOMA; TOOTH DISEASE;

EID: 84867360219     PISSN: 17248914     EISSN: 19713266     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Neufeld. Changes in the trabecular pattern of the mandible following the loss of teeth. J Prost Dent 1958;8(4):658-697.
2. Atwood A. Reduction of residual ridge: A major oral disease entity. J Prost Dent 1971;26(3):267-279.
3. Sanz M, van Winkelhoff AJ. Periodontal infections: understanding the complexity-consensus of the Seventh European Workshop on Periodontology. J Clin Periodontol 2011 Mar;38 Suppl 11:3-6.
4. Arron JR, Choy Y. Bone versus immune system. Nature 2000:408:535-536.
5. Graves DT, Oates T, Garlet GP. Review of osteoimmunology and the host response in endodontic and periodontal lesions. J Oral Microbiol 2011 Jan 17;3.
6. Armitage GC. development of a classification system for periodontal diseases and conditions. Ann Periodont 1999;vol 4(1):1-6.
7. Rylander H. Cause related periodontal therapy. In: Linde J. Clinical periodontology and implant dentistry. 4th edition: Blackwell Munksgaard; 2003:432-448.
8. Buduneli N, Kinane DF. Host-derived diagnostic markers related to soft tissue destruction and bone degradation in periodontitis. J Clin Periodontol 2011;38(suppl 11):85-105.
9. Amarasena N, Yoshiara A, Hirotomi T, et al. Association between serum calcium and periodontal disease progression in non-institutionalized elderly. Gerodontology 2008;25:245-250.
10. Duerte P M, from Rocha M, Sampaio E, et al. Serum levels of cytokines in subjects with generalized chronic and aggressive periodontitis before and after non-surgical perio- dontal therapy: a pilot study. Journal of Periodontology 2010;81:1056-1063.
11. Guentsch A, Puklo M, Preshaw PM, et al. Neutrophils in chronic and aggressive periodontitis in interaction with Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans. J of Periodontal Res 2009;44:368-377.
12. Marcaccini AM, Meschiari CA, Sorgi CA, et al. Circulating interleukin-6 and high sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects. J of Periodontol 2009;80:594-602.
13. Nakajima T, Honda T, Domon H, et al. Periodontitis-associated upregulation of systemic inflammatory mediator level may increase the risk of coronary heart disease. J Periodontal Res 2010;45:116-122.
14. Raunio T, Nixdorf M, Knuuttila M, et al. The extent of periodontal disease and the IL-6 - 174 genotype as determinants of serum IL-6 level. J Clin Periodontol 2007;34:1025-1030.
15. Renvert S, Lindahl C, Ross-JansakerAM, et al. Short-term effects of an anti- inflammatory treatment on clinical parameters and serum levels of C-reactive protein and proinflammatory cytokines in subjects with periodontitis. J Periodontol 2009;80:892-900.
16. Liu J, Wu Y, Ding Y, et al. Evaluation of serum levels of C-reactive protein and lipid profiles in patients with chronic periodontitis and/or coronary heart disease in an ethnic Han population. Quintessence Int 2010;41:239-247.
17. Offenbacher S, Beck JD, Moss K, et al. Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J Periodontol 2009;80:190-201.
18. Passoja A, Ylipalosaari M, Tervonen T, et al. Matrix metalloproteinase-8 concentration in shallow crevices associated with the extent of periodontal disease. J of Clin Periodontol 2008;35:1027-1031.
19. Ishisaka A, et al. Association of cortisol and dehydroepiandrosterone sulphate levels in serum with periodontal status in older Japanese adults. Journal of Clinical Periodontology 2008;35:853-861.
20. Iwasaki M, Ansai T, Soh I, et al. Longitudinal study on the relationship between serum albumin and periodontal disease. J Clinical Periodontol 2008;35:291-296.
21. Yoshihara A, Deguchi T, Hanada N, et al. Relation of bone turnover markers to periodontal disease and jaw bone morphology in elderly Japanese subjects. Oral Dis 2009;15:176-181.
22. Cochran DL. Inflammation and bone loss in periodontal disease. J Periodontol 2008;79:1569-1576.
23. Lappin DF, Sherrabeh S, Jenkins WM, et al. Effect of smoking on serum RANKL and OPG in sex, age and clinically matched supportive-therapy periodontitis patients. J Clin Periodontol 2007;34:271-277.
24. Lappin DF, Eapen B, Robertson D, et al. Markers of bone destruction and formation and periodontitis in type 1 diabetes mellitus. J Clin Periodontol 2009;36:634-641.
25. Özçaka O, Nalbantsoy A, Kose T, et al. Plasma osteoprotegerin levels are decreased in smoker chronic periodontitis patients. Aust Dent J 2010;55:405-410.
26. Sànchez-Riera L, Wilson N, Kamalaraj N, et al. Osteoporosis and fragility fractures. Best Pract Res Clin Rheumatol 2010 Dec;24(6):793-810.
27. Jeffcoat M. The Association Between Osteoporosis and Oral Bone Loss. J Periodontol 2005;76:2125-2132. (Pubitemid 41748962)
28. Klemetti E, Kolmakov S, Heiskanen P, et al. Panaromic mandibular index and bone mineral densities in postmenopausal women. Oral Surg Oral Med Oral Pathol 1993;75:774-9. (Pubitemid 23184725)
29. Klemetti E, Kolmakov S, Kroger H. Pantomography in assessment of the osteoporosis risk group. Scand J Dent Res 1994;102: 68-72.
30. Taguchi A, Sanada M, Krall E, et al. Relationship between dental panoramic radiographic findings and biochemical markers of bone turnover. J Bone Miner Res 2003;18:1689-95.
31. Garnero P, Delmas D P. Chapter 93: Measurements of Biochemical Markers: Methods and Limitations. In Bilezikian J.P. Principles of Bone Biology pp:1277-1292.
32. Deguchi T, Yoshiara A, Hanada N, et al. Relationship between mandibular inferior cortex and general bone metabolism in older adults. Osteoporos Int 2008;19:935-940.
33. Payne B, Stoner JA, Lee HM, et al. Serum Bone Biomarkers and Oral/Systemic Bone Loss in Humans. J Dent Res 2011;90:747-51.
34. Shear M. Developmental odontogenic cysts. An update. J Oral Pathol Med 1994 Jan;23(1):1-11.
35. Jones AV, Craig GT, Franklin CD. Range and demographics of odontogenic cysts diagnosed in a UK population over a 30-year period. J Oral Pathol Med 2006;sep35(8):500-7.
36. Ficarra G. Cisti delle ossa mascellari cap 16. In: Manuale di Patologia e Medicina Orale. III edizione, McGraw-Hill;2006:353-373.
37. Carlson ER. Odontogenic cysts and tumors (cap 30). In: Miloro M. Peterson's Principles of oral and maxillofacial surgery. Second edition, BC Decker Inc;2004:575-596.
38. Barnes L. Who classification of tumors. Pathology and genetics of the head and neck tumors. ARC Press.
39. KuroyanagiN, Sakuma H, Miyabe S, et al. Prognostic factors for keratocystic odontogenic tumor (odontogenic keratocyst): analysis of clinico-pathologic and immunohistochemical findings in cysts treated by enucleation. J Oral Pathol Med 2009; 38:386-392.
40. Kichi E, Enokiya Y, Muramatsu T, et al. Cell proliferation, apoptosis and apoptosis-related factors in odontogenic keratocysts and in dentigerous cysts. J Oral Pathol Med 2005;34:280-6. (Pubitemid 40524968)
41. Zhang L, Sun ZJ, Zhao YF, et al. Inhibition of SHH signaling pathway: molecular treatment strategy of odontogenic keratocyst. Med Hypotheses 2006;67(5):1242-4. (Pubitemid 44302262)
42. Baehni P, Tonetti MS. Conclusions and consensus statements on periodontal health, policy and education in Europe: a call for action - consensus view 1. Eur J Dent Educ 2010;14(Suppl. 1):2-3.
43. Lindhe J, Karring T, Lang N.P. Capitolo 18 Esame del paziente affetto da malattia parodontale. In Parodontologia clinica e odontoiatria implantare 4ed. Edi Ermes 2006.
44. Nagasawa T, Kiji M, Yashiro R, et al. Roles of receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin in periodontal health and disease. Periodontology 2000 2007;43:65-84.
45. Nakashima T, Kobayashi, Y, Yamasaki S, et al. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun 2000;275:768-775.
46. Bartold PM, Cantley MD, Haynes DR. Mechanisms and control of pathologic bone loss in periodontitis. Periodontology 2000;vol 53:55-69.
47. Wactawski-Wende J. Periodontal diseases and osteoporosis: association and mechanisms. Ann Periodontol 2001 Dec;6(1):197-208.
48. Jabbar S, Drury J, Forham J, et al. Plasma vitamin D and cytokines in periodontal disease and postmenopausal osteoporosis. J Periodontal Res 2011 Feb;46(1):97-104.
49. Sultan N, Rao J. Association between periodontal disease and bone mineral density in postmenopausal women: A cross sectional study. Med Oral Patol Oral Cir Bucal 2011 May 1;16 (3):e440-7.
50. Suresh S, Kumar TS, Saraswathy PK, et al. Periodontitis and bone mineral density among pre and post menopausal women: A comparative study. J Indian soc Periodontol 2010 Jan;14(1):30-4.
51. Passos J De S, Gomes-Filho IS, Viana MI, et al. Outcome Measurements in Studies on the Association Between Osteoporosis and Periodontal Disease. J Periodontol 2010;81:1773-1780.
52. Tay JY, Bay BH, Yeo JF, et al. Identification of RANKL in Osteolytic lesions of the facial skeleton. J Dent Res 2004;83(4):349-353. (Pubitemid 41713774)
53. Tekkesin MS, Mutlu S, Olgac V. The Role of RANK/RANKL/OPG Signalling Pathways in Osteoclastogenesis in Odontogenic Keratocysts, Radicular Cysts, and Ameloblastomas. Head and Neck Pathol 2011;5:248-253.
54. De Moraes M, de LucenaHF, de Azevedo PR, et al. Comparative immunohistochemical expression of RANK, RANKL and OPG in radicular and dentigerous cysts. Arch Oral Biol 2011;56:1256-1263.
55. Da Silva TA, Batista AC, Mendonca EF, et al. Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:333-41.
56. Menezes R, Bramante CM, da Silva Paiva KB, et al. Receptor activator NFκB-ligand and osteoprotegerin protein expression in human periapical cysts and granulomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102:404-9.
57. Andrade FR, Sousa DP, Mendoca EF, et al. Expression of bone resorption regulators (RANK, RANKL, and OPG) in odontogenic tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106:548-55.
58. Ali AM. Expression of extracellular matrix metalloproteinase inducer in odontogenic cysts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106:258-63.
59. Wang YP, Liu BY. High expression of osteopontin and CD44v6 in odontogenic keratocysts. J Formos Med Assoc 2009;108:286-292.
60. Serratì S, Tonelli P, Del Rosso M, et al. Urokinase and its receptor in follicular and inflammatory cysts of the jaws. Oral Dis 2010;16:753-759.
61. Tsai CH, Weng SF, Yang LC, et al. Immunohistochemical localization of tissue-type plasminogen activator and type I plasminogen activator inhibitor in radicular cysts. J Oral Pathol Med 2004;Mar33(3):156-61.
62. Yuan H, Gupte R, Zelkha S, et al. Receptor activator of nuclear factor kappa B ligand antagonists inhibit tissue inflammation and bone loss in experimental periodontitis J Clin Periodontol 2011;38:1029-1036.
63. Jin Q, Cirelli JA, Park CH, et al. RANKL Inhibition Through Osteoprotegerin Blocks Bone Loss in Experimental Periodontitis. J Periodontol 2007;78:1300-1308.